Unity Biotechnology (0YC0.L) Stock Price

$0.298 10.4%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    4
  • Fundamental

    1
  • Technical

    1

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Unity Biotechnology, AI stock picks, stock alerts and much more.

Sign up

0YC0.L AI Stock Analysis

AI stock analysis for 0YC0.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Unity Biotechnology (0YC0.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Unity Biotechnology (0YC0.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Unity Biotechnology (0YC0.L), currently trading at $0.298, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0YC0.L

LSE
  • Unity Biotechnology, Inc.

  • Symbol

    0YC0.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    5.1M

0YC0.L Alternative Data

Web Traffic

Unity Biotechnology receives an estimated 3264 monthly visitors to unitybiotechnology.com.

  • Web Traffic

    3264

  • Change from Previous Month

    13.1%

  • 3 Month Change

    35.9%

  • YoY Change

    35.9%

Twitter Followers

Unity Biotechnology has 5,394 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.

  • Twitter Followers

    5394

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1.5%

Youtube Subscribers

Unity Biotechnology has 188 subscribers on its main Youtube channel.

  • Youtube Subscribers

    188

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.5%

LinkedIn Followers

9,442 are following Unity Biotechnology on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    9442

  • Daily Change

    1%

  • 1 Month Change

    1%

  • 3 Month Change

    3.1%

Business Outlook

According to employee reviews, the business outlook among employees at Unity Biotechnology is 18 out of 100 (very bearish).

  • Business Outlook

    18

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Unity Biotechnology has 30 employees, down by -16.7% over the last month.

  • LinkedIn Employees

    30

  • Daily Change

    16.7%

  • 1 Month Change

    16.7%

  • 3 Month Change

    9.1%

News Mentions

Unity Biotechnology was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Unity Biotechnology has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

0YC0.L Financials

0YC0.L Key Metrics
  • Total Revenue

    $0

  • Net Income

    -$8.4M

  • Earnings per Share

    -$0.51

  • Free cash flow

    -$5.9M

  • EBITDA

    -$14.3M

  • EBITDA Ratio

    0

  • Total Assets

    $30.3M

0YC0.L 2-year Revenue & Income
0YC0.L 2-year Free Cash Flow

0YC0.L Technicals

0YC0.L SMA
0YC0.L RSI

FAQ

What's the current price of Unity Biotechnology (0YC0.L) Stock?
The price of an Unity Biotechnology (0YC0.L) share is $0.298.

What's the market cap of Unity Biotechnology?
The current market cap of Unity Biotechnology is 5.1M.

Should I buy or sell 0YC0.L?
Unity Biotechnology exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Unity Biotechnology a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Unity Biotechnology stock. There are several bearish signals and market challenges that could negatively impact Unity Biotechnology's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Unity Biotechnology (0YC0.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Unity Biotechnology stock right now, as the outlook appears bearish.

What are some stocks similar to Unity Biotechnology (0YC0.L) that investors often compare it to?
Unity Biotechnology (0YC0.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for Unity Biotechnology's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Unity Biotechnology's stock price to be around $0.274 in 2026. Starting from the current price of $0.298, this represents a 8.1% change in price, indicating a bearish outlook for the stock.

How to buy Unity Biotechnology (0YC0.L) Stock?
Unity Biotechnology stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Unity Biotechnology shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.